Patents by Inventor Ju Mi Hong

Ju Mi Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL LOBARIC ACID DERIVATIVE HAVING PTP-1B INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20220281805
    Abstract: A lobamide compound according to an embodiment of the present disclosure is represented by Formula 1. The lobamide compound has excellent PTP-1B inhibitory activity that is far higher than that of conventional lobaric acid derivatives and which can be orally administered, and thus is very effective in the prevention or treatment of diabetes or obesity through oral administration.
    Type: Application
    Filed: August 14, 2020
    Publication date: September 8, 2022
    Inventors: Joung Han YIM, Il Chan KIM, Se Jong HAN, Tai Kyoung KIM, Dong Gyu JO, Hyun Cheol OH, Ha Ju PARK, Seul Ki MIN, Sung Jin KIM, Pil Sung KANG, Min Ju KIM, Jung Eun KIM, Kyung Hee KIM, Ju Mi HONG
  • SKIN TREATMENT METHOD USING MEDICAL LASER, HAVING IMPROVED TREATMENT EFFICACY
    Publication number: 20220168589
    Abstract: Provided area an operating method for a laser device for skin, having improved treatment efficacy, or a treatment method for improving skin conditions. In the method according to an aspect, energy generated from a medical laser beam may be selectively transferred to a specific treatment area, which may be implemented in one device. Therefore, the method may contribute to improving the efficacy of laser treatment.
    Type: Application
    Filed: April 3, 2020
    Publication date: June 2, 2022
    Inventors: Hee Chul LEE, Ju Mi HONG
  • Cryoprotective agent containing exopolysaccharide from sp. CY01
    Patent number: 10993434
    Abstract: The present invention relates to an exopolysaccharide derived from Pseudoalteromonas sp. strain CY01 (KCTC 12867BP) which is a novel strain living in the polar regions, and to a composition for cryoprotection of cells, which contains the exopolysaccharide. The exopolysaccharide of the present invention has an excellent ability to cryoprotect cells, and shows no cytotoxicity. Thus, the inventive exopolysaccharide can substitute for conventional cryoprotective agents that show cytotoxicity when used at high concentrations.
    Type: Grant
    Filed: December 8, 2017
    Date of Patent: May 4, 2021
    Assignee: Korea Institute of Ocean Science and Technology
    Inventors: Joung Han Yim, Il-Chan Kim, Se Jong Han, Ui Joung Youn, Hong Kum Lee, Sung Jin Kim, Pil-Sung Kang, Jung Eun Kim, Tai Kyoung Kim, Ha Ju Park, Jin Haeng Song, Min Ju Kim, Ju Mi Hong, Dong-Gyu Jo
  • CRYOPROTECTIVE AGENT CONTAINING EXOPOLYSACCHARIDE FROM PSEUDOALTEROMONAS SP. CY01
    Publication number: 20180325101
    Abstract: The present invention relates to an exopolysaccharide derived from Pseudoalteromonas sp. strain CY01 (KCTC 12867BP) which is a novel strain living in the polar regions, and to a composition for cryoprotection of cells, which contains the exopolysaccharide. The exopolysaccharide of the present invention has an excellent ability to cryoprotect cells, and shows no cytotoxicity. Thus, the inventive exopolysaccharide can substitute for conventional cryoprotective agents that show cytotoxicity when used at high concentrations.
    Type: Application
    Filed: December 8, 2017
    Publication date: November 15, 2018
    Inventors: Joung Han Yim, Il-Chan Kim, Se Jong Han, Ui Joung Youn, Hong Kum Lee, Sung Jin Kim, Pil-Sung Kang, Jung Eun Kim, Tai Kyoung Kim, Ha Ju Park, Jin Haeng Song, Min Ju Kim, Ju Mi Hong, Dong-Gyu Jo